Series: Emerging Cancer Therapeutics V3 I2
John W. Sweetenham, MD, Jame Abraham, MD
208 pp Hardback
eISBN 9781617051319 |
Amazon Kindle | Google eBook
Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.
With contributions from internationally recognized experts, Lymphomas combines chapters on the evolving role of established therapies such as stem cell transplantation with other disease-oriented chapters describing pathway-directed agents and the evolving paradigm of "personalized" lymphoma treatment. Coverage includes discussion of molecular characterization for different disease-specific lymphoma subtypes and the potential for developing "personalized" treatment as well as reviewing the evolving role of conventional chemotherapy, stem cell transplantation, and other salvage treatments. The articles examine a range of lymphoma subtypes, including Hodgkin lymphoma, T-cell lymphoma, aggressive B-cell lymphoma, and others.- return to top -
ContentsNew Therapies in Hodgkin Lymphoma, Yasuhiro Oki and Anas Younes; Emerging Therapies in T-Cell Lymphoma, Alison J. Moskowitz and Steven M. Horwitz; Indolent Lymphoma: The Role and Impact of Novel Therapies, Stephen Smith and John William Sweetenham; Evolving Landscape in Mantle Cell Lymphoma: Emerging Trends and New Therapeutic Options, Andre Goy; Novel Pathways and Therapeutic Strategies for Aggressive B-Cell Lymphoma, Kieron Dunleavy, Cliona Grant, and Wyndham H. Wilson; Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma, Philip J. Bierman; Allogeneic Stem Cell Transplantation for Lymphoma, Stephen Mackinnon and Ronjon Chakraverty; Nontransplant-Based Salvage Therapy for Aggressive Lymphoma, Sophia Farooki and Michael Crump- return to top -
About the Guest Editors
John W. Sweetenham, MD
John W Sweetenham, MD, Professor of Medicine, Medical Director, UCSD Nevada Cancer Institute, Las Vegas, NVJame Abraham, MD
Jame Abraham, West Virginia University.